166 related articles for article (PubMed ID: 20537145)
21. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling.
Weerakiet S; Lertvikool S; Tingthanatikul Y; Wansumrith S; Leelaphiwat S; Jultanmas R
Gynecol Endocrinol; 2007; 23(8):455-60. PubMed ID: 17852413
[TBL] [Abstract][Full Text] [Related]
22. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
[TBL] [Abstract][Full Text] [Related]
23. Circulating tumor necrosis factor (TNF)-alpha in normally cycling women and patients with premature ovarian failure and polycystic ovaries.
Naz RK; Thurston D; Santoro N
Am J Reprod Immunol; 1995 Sep; 34(3):170-5. PubMed ID: 8561874
[TBL] [Abstract][Full Text] [Related]
24. Progesterone receptor membrane component 1 and its role in ovarian follicle growth.
Peluso JJ
Front Neurosci; 2013; 7():99. PubMed ID: 23781168
[TBL] [Abstract][Full Text] [Related]
25. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC
World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759
[TBL] [Abstract][Full Text] [Related]
26. Progestin and AdipoQ Receptor 7, Progesterone Membrane Receptor Component 1 (PGRMC1), and PGRMC2 and Their Role in Regulating Progesterone's Ability to Suppress Human Granulosa/Luteal Cells from Entering into the Cell Cycle.
Sueldo C; Liu X; Peluso JJ
Biol Reprod; 2015 Sep; 93(3):63. PubMed ID: 26203174
[TBL] [Abstract][Full Text] [Related]
27. Conditional Ablation of Progesterone Receptor Membrane Component 2 Causes Female Premature Reproductive Senescence.
Clark NC; Pru CA; Yee SP; Lydon JP; Peluso JJ; Pru JK
Endocrinology; 2017 Mar; 158(3):640-651. PubMed ID: 28005395
[TBL] [Abstract][Full Text] [Related]
28. Can we use serum Anti-Mullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patients and healthy women with polycystic ovarian morphology and regular menstrual cycles.
Aydoğmuş H; Kelekçi S; Elmalı F; Aydoğmuş S
Saudi Med J; 2018 Oct; 39(10):1011-1016. PubMed ID: 30284584
[TBL] [Abstract][Full Text] [Related]
29. Proteomic Profiling for Identification of Novel Biomarkers Differentially Expressed in Human Ovaries from Polycystic Ovary Syndrome Patients.
Li L; Zhang J; Deng Q; Li J; Li Z; Xiao Y; Hu S; Li T; Tan Q; Li X; Luo B; Mo H
PLoS One; 2016; 11(11):e0164538. PubMed ID: 27846214
[TBL] [Abstract][Full Text] [Related]
30. Chronic hyperandrogenemia in the presence and absence of a western-style diet impairs ovarian and uterine structure/function in young adult rhesus monkeys.
Bishop CV; Mishler EC; Takahashi DL; Reiter TE; Bond KR; True CA; Slayden OD; Stouffer RL
Hum Reprod; 2018 Jan; 33(1):128-139. PubMed ID: 29190387
[TBL] [Abstract][Full Text] [Related]
31. Progesterone, Inflammatory Cytokine (TNF-α), and Oxidative Stress (H2O2) Regulate Progesterone Receptor Membrane Component 1 Expression in Fetal Membrane Cells.
Meng Y; Murtha AP; Feng L
Reprod Sci; 2016 Sep; 23(9):1168-78. PubMed ID: 26919974
[TBL] [Abstract][Full Text] [Related]
32. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
Rudnicka E; Kunicki M; Radowicki S
Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
[TBL] [Abstract][Full Text] [Related]
33. Progesterone receptor membrane component 1 (PGRMC1) expression in fetal membranes among women with preterm premature rupture of the membranes (PPROM).
Feng L; Antczak BC; Lan L; Grotegut CA; Thompson JL; Allen TK; Murtha AP
Placenta; 2014 May; 35(5):331-3. PubMed ID: 24680695
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of nuclear progestin receptor (Pgr) and subfertility in double knockouts of progestin receptor membrane component 1 (pgrmc1) and pgrmc2 in zebrafish.
Wu XJ; Zhu Y
Gen Comp Endocrinol; 2020 Jan; 285():113275. PubMed ID: 31536721
[TBL] [Abstract][Full Text] [Related]
35. PGRMC1 in animal breast cancer tissue and blood is associated with increased tumor growth with norethisterone in contrast to progesterone and dydrogesterone: four-arm randomized placebo-controlled xenograft study.
Cai G; Ruan X; Gu M; Zhao Y; Wang Y; Mueck AO
Gynecol Endocrinol; 2020 Nov; 36(11):1024-1027. PubMed ID: 32208774
[TBL] [Abstract][Full Text] [Related]
36. Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action.
Peluso JJ; Pappalardo A; Losel R; Wehling M
Endocrinology; 2006 Jun; 147(6):3133-40. PubMed ID: 16513825
[TBL] [Abstract][Full Text] [Related]
37. Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.
Mir SU; Ahmed IS; Arnold S; Craven RJ
Int J Cancer; 2012 Jul; 131(2):E1-9. PubMed ID: 21918976
[TBL] [Abstract][Full Text] [Related]
38. The role of mTOR in ovarian Neoplasms, polycystic ovary syndrome, and ovarian aging.
Liu J; Wu DC; Qu LH; Liao HQ; Li MX
Clin Anat; 2018 Sep; 31(6):891-898. PubMed ID: 29752839
[TBL] [Abstract][Full Text] [Related]
39. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
40. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
Adams JM; Taylor AE; Crowley WF; Hall JE
J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
